Sign in
4

Changes in Ownership

PDS Biotechnology Corp Filed Acc 0001140361-20-003645

Chief Financial Officer acquired 38,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Saik Andrew Chief Financial Officer 2020-02-14 Grant or award +38,400 $1.30 $49,920 42,549 D: show line 1 in the form
Loading xslF345X03/form4.xml…